Vet Pathol Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (19)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, M. E.
Right arrow Articles by Howerth, E. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, M. E.
Right arrow Articles by Howerth, E. W.
Vet Pathol 41:599-607 (2004)
© 2004 American College of Veterinary Pathologists


Review Article

Survivin: A Bifunctional Inhibitor of Apoptosis Protein

M. E. Johnson and E. W. Howerth

Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA

Survivin is a recently discovered protein belonging to the inhibitor of apoptosis (IAP) gene family. IAP molecules are characterized by both the presence of a zinc-binding fold termed the baculoviral IAP repeat and the ability to suppress apoptosis. In addition to inhibiting apoptosis, survivin is essential for proper cell division. Survivin is expressed during embryonal development but is absent in most normal, terminally differentiated tissues. Survivin is also upregulated in a variety of human cancers, and its expression in tumors is associated with a more aggressive phenotype, shorter survival times, and a decreased response to chemotherapy. The exact mechanism behind the ability of survivin to inhibit apoptosis is still unclear. Furthermore, it is not known why this protein is upregulated in cancer. The purpose of this article is to provide an overview of the current knowledge of survivin, including its role in cell division and its expression in normal and neoplastic tissues. Although much of the current research in this field is focused on human medicine, this area also has potential significance for veterinary species.


Key words: Cancer; cell division; inhibitor of apoptosis; review; survivin.

Request reprints from Dr. M. E. Johnson, Department of Pathology, College of Veterinary Medicine, University of Georgia, Athens, GA 30602 (USA). E-mail: mjohnson{at}vet.uga.edu




This article has been cited by other articles:


Home page
Molecular Cancer TherapeuticsHome page
M. E. Ramos-Nino and B. Littenberg
A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by down-regulating Fra-1 and Survivin in cancer cells
Mol. Cancer Ther., July 1, 2008; 7(7): 1871 - 1879.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Lechler, X. Wu, W. Bernhardt, V. Campean, S. Gastiger, T. Hackenbeck, B. Klanke, A. Weidemann, C. Warnecke, K. Amann, et al.
The Tumor Gene Survivin Is Highly Expressed in Adult Renal Tubular Cells: Implications for a Pathophysiological Role in the Kidney
Am. J. Pathol., November 1, 2007; 171(5): 1483 - 1498.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Veterinary Pathologists.